Amgen Inc.
US ˙ NasdaqGS ˙ US0311621009

SecurityAMGN / Amgen Inc.
InstitutionHalbert Hargrove Global Advisors, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Halbert Hargrove Global Advisors, Llc closes position in AMGN / Amgen Inc.

On January 23, 2026 - Halbert Hargrove Global Advisors, Llc filed a 13F-HR form disclosing ownership of 0 shares of Amgen Inc. (US:AMGN) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 16, 2025 disclosing 39 shares of Amgen Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-23 2025-12-31 13F AMGEN COM 031162100 0 -100.00 0
2025-10-16 2025-09-30 13F AMGEN COM 031162100 39 39 11 0.0005
2025-07-17 2025-06-30 13F AMGEN COM 031162100 0 -33 -100.00 0 -100.00
2025-04-18 2025-03-31 13F AMGEN COM 031162100 33 33 10 0.0006
2023-08-14 2023-06-30 13F AMGEN COM 031162100 0 -1,254 -100.00 0 -100.00
2023-04-25 2023-03-31 13F AMGEN COM 031162100 1,254 -21 -1.65 303 -9.28 0.0205
2023-01-25 2022-12-31 13F AMGEN COM 031162100 1,275 67 5.55 335 22.79 0.0239
2022-10-24 2022-09-30 13F AMGEN COM 031162100 1,208 56 4.86 272 -2.86 0.0210
2022-08-05 2022-06-30 13F AMGEN COM 031162100 1,152 33 2.95 280 3.32 0.0208
2022-05-13 2022-03-31 13F AMGEN COM 031162100 1,119 38 3.52 271 11.52 0.0179
2022-02-14 2021-12-31 13F AMGEN COM 031162100 1,081 -79 -6.81 243 -1.62 0.0155
2021-10-29 2021-09-30 13F AMGEN COM 031162100 1,160 -309 -21.03 247 -31.01 0.0172
2021-07-29 2021-06-30 13F AMGEN COM 031162100 1,469 314 27.19 358 24.74 0.0235
2021-05-06 2021-03-31 13F AMGEN COM 031162100 1,155 29 2.58 287 10.81 0.0206
2021-02-04 2020-12-31 13F AMGEN COM 031162100 1,126 3 0.27 259 -9.12 0.0196
2020-11-10 2020-09-30 13F AMGEN COM 031162100 1,123 31 2.84 285 10.47 0.0274
2020-08-10 2020-06-30 13F AMGEN COM 031162100 1,092 -53 -4.63 258 11.21 0.0379
2020-05-01 2020-03-31 13F AMGEN COM 031162100 1,145 33 2.97 232 -13.43 0.0405
2020-02-12 2019-12-31 13F AMGEN COM 031162100 1,112 -65 -5.52 268 17.54 0.0692
2019-11-12 2019-09-30 13F AMGEN COM 031162100 1,177 77 7.00 228 12.32 0.0605
2019-07-26 2019-06-30 13F AMGEN COM 031162100 1,100 -4 -0.36 203 -3.33 0.0551
2019-05-13 2019-03-31 13F AMGEN COM 031162100 1,104 -9 -0.81 210 -3.23 0.7403
2019-02-11 2018-12-31 13F AMGEN COM 031162100 1,113 3 0.27 217 -5.65 0.0499
2018-10-31 2018-09-30 13F AMGEN COM 031162100 1,110 -51 -4.39 230 7.48 0.0597
2018-08-10 2018-06-30 13F AMGEN COM 031162100 1,161 -12 -1.02 214 7.00 0.0564
2018-05-01 2018-03-31 13F AMGEN COM 031162100 1,173 1,173 200 0.0530
2018-02-01 2017-12-31 13F AMGEN COM 031162100 0 -1,099 -100.00 0 -100.00
2017-11-02 2017-09-30 13F AMGEN COM 031162100 1,099 1,099 205 0.0564
2017-02-09 2016-12-31 13F AMGEN COM 031162100 0 -1,337 -100.00 0 -100.00
2016-11-09 2016-09-30 13F AMGEN COM 031162100 1,337 -162 -10.81 223 -2.19 0.0627
2016-08-08 2016-06-30 13F AMGEN COM 031162100 1,499 52 3.59 228 5.07 0.0653
2016-05-12 2016-03-31 13F AMGEN COM 031162100 1,447 -234 -13.92 217 -20.51 0.0780
2016-02-03 2015-12-31 13F AMGEN COM 031162100 1,681 -74 -4.22 273 12.35 0.1174
2015-11-12 2015-09-30 13F AMGEN COM 031162100 1,755 -1,831 -51.06 243 -55.90 0.1194
2015-08-11 2015-06-30 13F AMGEN COM 031162100 3,586 -160 -4.27 551 -8.01 0.1340
2015-05-01 2015-03-31 13F AMGEN COM 031162100 3,746 1,562 71.52 599 72.13 0.1922
2015-02-18 2014-12-31 13F AMGEN COM 031162100 2,184 10 0.46 348 14.10 0.1733
2014-11-12 2014-09-30 13F AMGEN COM 031162100 2,174 -1,496 -40.76 305 -32.67 0.0842
2014-05-02 2014-03-31 13F AMGEN COM 031162100 3,670 -198 -5.12 453 2.72 0.1392
2014-02-07 2013-12-31 13F AMGEN COM 031162100 3,868 -81 -2.05 441 -0.23 0.1362
2013-11-14 2013-09-30 13F AMGEN COM 031162100 3,949 6 0.15 442 13.62 0.1465
2013-08-15 2013-06-30 13F AMGEN COM 031162100 3,943 3,943 389 0.1425
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.